William Heiden
Chairman at MACROGENICS, INC.
Net worth: 251 300 $ as of 29/04/2024
William Heiden active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Director/Board Member | 22/11/2015 | - |
| Independent Dir/Board Member | 22/11/2015 | - | |
| MACROGENICS, INC. | Chairman | 21/05/2022 | - |
| Independent Dir/Board Member | 21/05/2022 | - | |
Third Pole, Inc.
 Third Pole, Inc. Medical SpecialtiesHealth Technology Third Pole, Inc. engages in the development of cardiopulmonary therapies. Its product is capable of generating nitric oxide from air and electricity. The company is headquartered in San Francisco, CA. | Director/Board Member | 23/02/2021 | - |
Career history of William Heiden
Former positions of William Heiden
| Companies | Position | Start | End |
|---|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Director/Board Member | 13/05/2012 | 27/04/2020 |
| Chief Executive Officer | 13/05/2012 | 27/04/2020 | |
| President | 29/04/2017 | 27/04/2020 | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 17/07/2016 | 30/04/2017 |
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Director/Board Member | 28/07/2010 | 30/09/2013 |
| REVO BIOLOGICS INC | Director/Board Member | 04/10/2009 | 17/06/2010 |
| Chairman | 17/06/2010 | 25/04/2013 | |
| Public Communications Contact | 28/07/2010 | 07/04/2011 | |
| President | 17/06/2010 | 15/05/2012 | |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Director/Board Member | 31/08/2004 | 30/11/2008 |
| Chief Executive Officer | 31/08/2004 | 30/11/2008 | |
| President | 31/08/2004 | - | |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Chief Operating Officer | 09/05/2002 | - |
| President | 09/05/2002 | - | |
| ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
| ░░░░░░░░░ | - | - | |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░ ░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of William Heiden
| University of Florida | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
| Université Catholique de Louvain | Graduate Degree |
Statistics
International
| United States | 14 |
| France | 3 |
| Canada | 2 |
Operational
| Director/Board Member | 11 |
| President | 5 |
| Chief Executive Officer | 3 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 4 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Miscellaneous |
Managed Health Care Associates, Inc.
 Managed Health Care Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Managed Health Care Associates, Inc. provides management and information technology support services to the healthcare industry. It operates as a health care services and technology company that offers a portfolio of services and solutions to support the diverse and complex needs of the alternate site health care providers. The firm specializes in group purchasing, managed care and payer contracting, reimbursement management, specialty pharmacy solutions, pharmaceutical data analytics, consultant pharmacy software and legislative advocacy services. The company was founded in 1989 and is headquartered in Florham Park, NJ. | Commercial Services |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
Third Pole, Inc.
Third Pole, Inc. Medical SpecialtiesHealth Technology Third Pole, Inc. engages in the development of cardiopulmonary therapies. Its product is capable of generating nitric oxide from air and electricity. The company is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- William Heiden
- Experience
